TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12632889

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (group A, 72 patients) starting 15 days after CABG
Number of subjects: 103

Group type: COMPARATOR
Intervention: No cardiac rehabilitation (group B, 31 patients)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (group A)
Number of subjects: 103
Study: 10227630

Group type: COMPARATOR
Intervention: 25 mug/kg BDNF
Number of subjects: 1135

Group type: COMPARATOR
Intervention: 100 mug/kg BDNF
Number of subjects: 1135

Group type: COMPARATOR
Intervention: 100 mug/kg BDNF (in patients with baseline forced vital capacity of <91%)
Number of subjects: 1135

Group type: COMPARATOR
Intervention: 100 mug/kg BDNF (in patients reporting altered bowel function)
Number of subjects: 1135
Study: 7782581

Group type: EXPERIMENTAL
Intervention: CO2 laser treatment for cervical intraepithelial neoplasia
Number of subjects: 1114

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 1114
Study: 2212146

Group type: EXPERIMENTAL
Intervention: Viprostol
Number of subjects: 57

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 321991

Group type: EXPERIMENTAL
Intervention: Dimethothiazine, 60 mg/day for 2 to 3-4 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31974939

Group type: EXPERIMENTAL
Intervention: Triple conjunction search task (Task 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plus conjunction search task (Task 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between triple and plus conjunction search tasks
Number of subjects: 0
Study: 30326732

Group type: EXPERIMENTAL
Intervention: 5-s TASER shock
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 26886509

Group type: EXPERIMENTAL
Intervention: Single-Incision Sling (SIS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tension-Free Transobturator Suburethral Tape (TVT-O)
Number of subjects: 48
Study: 25249789

Group type: EXPERIMENTAL
Intervention: BIS-guided anesthesia
Number of subjects: 294

Group type: COMPARATOR
Intervention: MAC-guided anesthesia
Number of subjects: 294
Study: 23168581

Group type: EXPERIMENTAL
Intervention: ARA 290 (2 mg, intravenous, three times weekly for 4 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 20164296

Group type: COMPARATOR
Intervention: Alendronate 10 mg daily
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Teriparatide 40 microg sc daily
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both alendronate and teriparatide
Number of subjects: 93
Study: 18478937

Group type: EXPERIMENTAL
Intervention: High dose thymopentin (10 mg/d) combined with trans-artery chemoembolization (TACE) with oxaliplatin 150 mg, pharmorubicin 50 mg, 5‐Fu 750 mg, CF 300 mg and lipiodol 20 ml.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Trans-artery chemoembolization (TACE) with oxaliplatin 150 mg, pharmorubicin 50 mg, 5‐Fu 750 mg, CF 300 mg and lipiodol 20 ml.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High dose thymopentin (10 mg/d) combined with TACE.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Trans-artery chemoembolization (TACE) with oxaliplatin, pharmorubicin, 5‐Fu, CF and lipiodol.
Number of subjects: 50
Study: 16305967

Group type: EXPERIMENTAL
Intervention: Needling in Baihui (DU20), Shuigou (DU26) and Shenmen (HT7)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Routine acupoints for hemiplegia (control group)
Number of subjects: 10
Study: 12152996

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1250 mg/mq (days 1, 8 and 15) as a single agent for 3 monthly courses
Number of subjects: 16

Group type: COMPARATOR
Intervention: Gemcitabine 1000 mg/mq (days 1, 8 and 15) plus cisplatin 80 mg/mq (day 1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Time to treatment failure (TTF)
Number of subjects: 16
Study: 10622647

Group type: EXPERIMENTAL
Intervention: Rocuronium 2x ED95
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rocuronium 3x ED95
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rocuronium (both doses)
Number of subjects: 20
Study: 8622102

Group type: EXPERIMENTAL
Intervention: Isepamicin 8 or 15 mg/kg once daily
Number of subjects: 185

Group type: COMPARATOR
Intervention: Amikacin 7.5 mg/kg twice daily
Number of subjects: 185
Study: 10148919

Group type: EXPERIMENTAL
Intervention: Lithotripsy plus ursodiol (Actigall, Ciba Geigy)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lithotripsy alone
Number of subjects: 100
Study: 6893580

Group type: EXPERIMENTAL
Intervention: 2 mg sublingual molsidomine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30797692

Group type: EXPERIMENTAL
Intervention: Acupressure at true acupoints
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 62
Study: 28228368

Group type: EXPERIMENTAL
Intervention: Web-based, Spanish-language, individually tailored physical activity intervention
Number of subjects: 205

Group type: COMPARATOR
Intervention: Wellness contact control
Number of subjects: 205
Study: 25751447

Group type: EXPERIMENTAL
Intervention: Massage intervention
Number of subjects: 117

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 117
Study: 24383496

Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated VPS
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Silver-impregnated VPS
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Standard silicone VPS (comparator)
Number of subjects: 1200
Study: 21967645

Group type: EXPERIMENTAL
Intervention: Ticagrelor 270 mg (3×90 mg tablets) after a 10-h overnight fast
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ticagrelor 270 mg (3×90 mg tablets) after a standard high-fat, high-calorie breakfast
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ticagrelor after a standard high-fat, high-calorie breakfast
Number of subjects: 26

Group type: COMPARATOR
Intervention: AR-C124910XX after a standard high-fat, high-calorie breakfast
Number of subjects: 26
Study: 19296870

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50 microg or 2000 IU daily for 12 weeks)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo (matching placebo for 12 weeks)
Number of subjects: 162
Study: 17469042

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 15094148

Group type: COMPARATOR
Intervention: Tai Chi gait (TCG)
Number of subjects: 10
Study: 11989392

Group type: EXPERIMENTAL
Intervention: Exogenous hyaluronan administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyaluronan-based biomaterials
Number of subjects: 0
Study: 9764566

Group type: EXPERIMENTAL
Intervention: Radiographers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonradiographers
Number of subjects: 0
Study: 1399475

Group type: EXPERIMENTAL
Intervention: Percutaneous long line silastic catheters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional intravenous cannulas
Number of subjects: 0
Study: 3540879

Group type: EXPERIMENTAL
Intervention: Suprofen 200 mg
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Suprofen 400 mg
Number of subjects: 224

Group type: COMPARATOR
Intervention: Aspirin 650 mg
Number of subjects: 224

Group type: COMPARATOR
Intervention: Codeine 60 mg
Number of subjects: 224

Group type: COMPARATOR
Intervention: Propoxyphene HCl 65 mg
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224

Group type: COMPARATOR
Intervention: Aspirin 650 mg with codeine 60 mg
Number of subjects: 224
Study: 31442848

Group type: EXPERIMENTAL
Intervention: Serious game
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (text-based material)
Number of subjects: 27
Study: 30326872

Group type: EXPERIMENTAL
Intervention: Individual placement and support
Number of subjects: 96

Group type: COMPARATOR
Intervention: Traditional vocational rehabilitation
Number of subjects: 96
Study: 26438656

Group type: EXPERIMENTAL
Intervention: BIS values maintained at <50 (Group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: BIS values maintained at ≥50 with 4-7% desflurane in a 50% O2-air mixture (Group 2)
Number of subjects: 60
Study: 24641522

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate (CP) 0.05% ointment
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MMF) 0.1% ointment
Number of subjects: 54
Study: 22581482

Group type: EXPERIMENTAL
Intervention: Worry exposure therapy (n = 29)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Applied relaxation therapy (n = 27)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Healthy participants (control group, n = 33)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Post therapy (immediate outcome)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Long-term follow-up (6- and 12-month)
Number of subjects: 56
Study: 19504425

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nystatin
Number of subjects: 80
Study: 17653011

Group type: EXPERIMENTAL
Intervention: Ulinastatin (1000000 U total dose)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16671340

Group type: EXPERIMENTAL
Intervention: Cilnidipine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 110
Study: 11991872

Group type: EXPERIMENTAL
Intervention: Manual aspiration
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chest tube drainage
Number of subjects: 60
Study: 9471043

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate (HoLEP) combined with mechanical morcellation
Number of subjects: 14
Study: 7551644

Group type: EXPERIMENTAL
Intervention: Causal models of factors affecting coronary heart disease risk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preventive actions rated by individuals
Number of subjects: 0
Study: 2154314

Group type: EXPERIMENTAL
Intervention: Brachytherapy alone or with external beam radiation therapy or surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraoperative radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperthermia with radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Particle irradiation (protons, neutrons, stripped nuclei, and pions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infusional (intravenous) chemotherapy with radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraarterial monoclonal antibodies with radionuclides and intraarterial chemotherapy with radiation therapy
Number of subjects: 0
Study: 7357805

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% ophthalmic solution (2 drops to each eye with precautions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% ophthalmic solution (1 drop to each eye with no special precautions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Timolol 0.5% ophthalmic solution
Number of subjects: 0
Study: 30778518

Group type: EXPERIMENTAL
Intervention: Structured physical activity intervention
Number of subjects: 1022

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 1022
Study: 28665470

Group type: EXPERIMENTAL
Intervention: Local Brain Radiotherapy (LBRT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Whole Brain Radiotherapy (WBRT)
Number of subjects: 54
Study: 26436683

Group type: EXPERIMENTAL
Intervention: Day Camp Intervention Arm (DCIA)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard Intervention Arm (SIA)
Number of subjects: 115
Study: 22729611

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus multitargeted antiangiogenic TKI
Number of subjects: 3337
Study: 20732768

Group type: EXPERIMENTAL
Intervention: EGFR overexpression (high levels)
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: EGFR combined with clinical parameters
Number of subjects: 533
Study: 19241490

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Higher family support
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Poor physical health, depressive symptoms, and lower emotional HRQL
Number of subjects: 227
Study: 16754825

Group type: EXPERIMENTAL
Intervention: Home-based asthma education intervention
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 221
Study: 14679127

Group type: EXPERIMENTAL
Intervention: Topotecan (1.5 mg/m(2)/day for 5 days)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Paclitaxel (175 mg/m(2)/day as a 3‐h infusion every 21 days)
Number of subjects: 226
Study: 11689808

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (3 microg. kg. min(‐1))
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (bolus injection of 2 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (preischemic values)
Number of subjects: 48
Study: 9039301

Group type: EXPERIMENTAL
Intervention: Calcipotriol cream (50 micrograms/g)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Betamethasone 17-valerate cream (1 mg/g)
Number of subjects: 421
Study: 8133350

Group type: EXPERIMENTAL
Intervention: Let Me Decide directive
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Medical Directive
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: No preference
Number of subjects: 128
Study: 2774051

Group type: EXPERIMENTAL
Intervention: Prone standing position
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sitting and prone standing positions
Number of subjects: 10
Study: 127815

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 0
Study: 31444008

Group type: EXPERIMENTAL
Intervention: Ketorolac 0.5%
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Prednisolone 1%
Number of subjects: 85

Group type: COMPARATOR
Intervention: Saline tears (placebo)
Number of subjects: 85
Study: 24927783

Group type: EXPERIMENTAL
Intervention: Qigong intervention plus usual care and rehabilitation (N = 29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care and rehabilitation alone (N = 29)
Number of subjects: 58
Study: 23416451

Group type: EXPERIMENTAL
Intervention: Behavioral and fMRI evidence supporting event representations coalescing around clusters of mutually predicting stimuli.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fMRI adaptation and multivoxel pattern analysis techniques used to analyze event representations.
Number of subjects: 0
Study: 21995829

Group type: EXPERIMENTAL
Intervention: Offering survey results as an incentive
Number of subjects: 4796

Group type: COMPARATOR
Intervention: Control group (no offer of results)
Number of subjects: 4796
Study: 19950738

Group type: EXPERIMENTAL
Intervention: Minimal acute normovolemic hemodilution (ANH)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 101
Study: 18028979

Group type: EXPERIMENTAL
Intervention: Object axes allowing for the highest orientation discrimination (horizontal/vertical)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Method of adjustment
Number of subjects: 0
Study: 15037415

Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 3 mg of drospirenone + 30 microg of ethinyl estradiol (DRSP + EE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group studied during the first menstrual cycle at the follicular phase and at the luteal phase, and during the third cycle at the luteal phase
Number of subjects: 22
Study: 11722416

Group type: EXPERIMENTAL
Intervention: Serum transferrin receptor (sTfR) and TfR-Index
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: LogTfR:Fer ratio
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: LogTfR:Fer ratio after resolution of inflammation
Number of subjects: 561
Study: 9230571

Group type: EXPERIMENTAL
Intervention: Evolving Consumer Households
Number of subjects: 112

Group type: COMPARATOR
Intervention: Independent Living apartments
Number of subjects: 112
Study: 7735152

Group type: EXPERIMENTAL
Intervention: Contralateral acoustic stimulation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intra-subject test results (n = 18)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TEOAE suppression measurements
Number of subjects: 12
Study: 3320785

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29073802

Group type: EXPERIMENTAL
Intervention: Occlusal appliance (OA)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Relaxation training (RT) combined with information (Control group)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Sequential treatment (ST)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Overall comparison of OA vs RT/Co
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 116
Study: 28315780

Group type: EXPERIMENTAL
Intervention: Proposed NFL with AS in grams plus high/medium/low text
Number of subjects: 2509

Group type: EXPERIMENTAL
Intervention: Proposed NFL with AS in grams and %DV
Number of subjects: 2509

Group type: COMPARATOR
Intervention: Current NFL without AS
Number of subjects: 2509

Group type: EXPERIMENTAL
Intervention: Proposed NFL with AS in grams only
Number of subjects: 2509

Group type: EXPERIMENTAL
Intervention: Proposed NFL with AS in teaspoons
Number of subjects: 2509

Group type: EXPERIMENTAL
Intervention: %DV for determining healthier products
Number of subjects: 2509

Group type: EXPERIMENTAL
Intervention: Grams alone for determining healthier products
Number of subjects: 2509

Group type: COMPARATOR
Intervention: No label
Number of subjects: 2509
Study: 25745357

Group type: EXPERIMENTAL
Intervention: CI increased group
Number of subjects: 29

Group type: COMPARATOR
Intervention: CI constant group
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CI percent change
Number of subjects: 29
Study: 23169400

Group type: EXPERIMENTAL
Intervention: Rating of constituents' needs or opinions as a factor influencing health policy priorities
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Rating of evidence of scientific effectiveness as a factor influencing health policy priorities
Number of subjects: 75
Study: 22276506

Group type: EXPERIMENTAL
Intervention: QRHX decoction (composed of Huangbai, Chishao, Bixie, Danshen, Ezhu, Qingfengteng, raw Huangqi, Jinyinhua, Tufuling, Wugong, Fengfang, raw Yiyiren, cooked with water as 400 ml liquid)
Number of subjects: 86

Group type: COMPARATOR
Intervention: QRHX decoction plus methotrexate (MTX)
Number of subjects: 86
Study: 19590482

Group type: EXPERIMENTAL
Intervention: Acupuncture (8 sessions over 4 weeks)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Steroid treatment (prednisolone 20 mg daily for 2 weeks followed by 10 mg daily for 2 weeks)
Number of subjects: 77
Study: 16876164

Group type: EXPERIMENTAL
Intervention: Basigin expression in ovarian endometriotic tissue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basigin expression in eutopic endometrium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basigin expression in endometriotic lesions
Number of subjects: 0
Study: 12632273

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with biweekly FOLFOX regimen (FOL: 500 mg/m2, F: 2000 mg/m2 for 2 days, OX: 85 mg/m2)
Number of subjects: 42
Study: 11108443

Group type: EXPERIMENTAL
Intervention: Local nasal immunotherapy (LNIT) with powder extract of Graminaceae or Parietaria pollens
Number of subjects: 43

Group type: COMPARATOR
Intervention: Symptomatic pharmacological treatment only (Control)
Number of subjects: 43
Study: 8601647

Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg daily (21 patients)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Terbinafine 500 mg daily for 1 week every month (21 patients)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Itraconazole 400 mg daily for 1 week every month (21 patients)
Number of subjects: 63
Study: 1458859

Group type: EXPERIMENTAL
Intervention: Computer program (group A)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 39
Study: 6463598

Group type: EXPERIMENTAL
Intervention: Thiazide (50 mg hydrochlorthiazide)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 30802196

Group type: EXPERIMENTAL
Intervention: Intravenous sufentanil (1 μg/kg) and midazolam (0.2 mg/kg) (Group SM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Inhalational sevoflurane (2.0 MAC) (Group S)
Number of subjects: 44
Study: 28619016

Group type: EXPERIMENTAL
Intervention: Endoscopic mask oxygen-providing (3 L/min during intubation)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Nasal catheter oxygen-providing
Number of subjects: 54
Study: 26974018

Group type: EXPERIMENTAL
Intervention: Rocuronium 1 mg/kg reversed with Sugammadex 2-4 mg/kg
Number of subjects: 240

Group type: COMPARATOR
Intervention: Suxamethonium 1 mg/kg for induction, Rocuronium 0.3 mg/kg for maintenance, Neostigmine 0.03 mg/kg for reversal
Number of subjects: 240
Study: 23253641

Group type: EXPERIMENTAL
Intervention: Computerized cognitive behavioural therapy (cCBT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Computer-administered attention placebo program with psychoeducational content (CPE)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: cCBT
Number of subjects: 34

Group type: COMPARATOR
Intervention: CPE
Number of subjects: 34
Study: 22768645

Group type: EXPERIMENTAL
Intervention: Simulated vehicles in quiet settings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simulated vehicles with moderate background traffic sound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Signal-to-noise ratio for straight-or-turn judgment
Number of subjects: 0
Study: 19222417

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 3151

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg
Number of subjects: 3151

Group type: EXPERIMENTAL
Intervention: Positive Helicobacter pylori status
Number of subjects: 3151

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 3151

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 3151

Group type: EXPERIMENTAL
Intervention: No acid regurgitation or epigastric pain pre-treatment
Number of subjects: 3151